Multifocal motor neuropathy: Diagnosis and treatment

Neurology

Volumn 51, Issue 6 SUPPL. 5, 1998, Pages

  Pestronk, Alan ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8111 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GANGLIOSIDE GM1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE;

ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONFUSION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FASCICULATION; HUMAN; IMMUNE MEDIATED INJURY; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; NERVE BLOCK; PARESTHESIA; PRIORITY JOURNAL; PROTEIN BINDING; SPASTICITY; TENDON REFLEX;

ANTIBODIES; ELECTRODIAGNOSIS; G(M1) GANGLIOSIDE; HUMANS; MOTOR NEURON DISEASE;

EID: 0032407091     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kornberg AJ, Pestronk A. Chronic motor neuropathies: Diagnosis, therapy, and pathogenesis. Ann Neurol 1995;37(Suppl 1):S43-50.
2. Pestronk A. Chronic immune polyneuropathies and serum autoantibodies. In: Rolak LA, Harati Y, eds. Neuroimmunology for the clinician. Boston: Butterworth-Heinemann, 1997:237-252.
3. Parry G. Motor neuropathy with multifocal conduction block. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. 3rd ed. Philadelphia: WB Saunders, 1993:1518-1524.
4. Pestronk A, Chaudhry V, Feldman EL, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol 1990;27:316-326.
5. Feasby TE, Brown WF, Gilbert JJ, Hahn AF. The pathological basis of conduction block in human neuropathies. J Neurol Neurosurg Psychiatry 1985;48:239-244.
6. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
7. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol 1990;28:146-156.
8. Pestronk A, Choksi R. Multifocal motor neuropathy: serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997;49:1289-1292.
9. Pestronk A, Choksi R, Blume G, Lopate G. Multifocal motor neuropathy: serum IgM binding to a GM1-ganglioside containing lipid mixture but not to GM1 alone. Neurology 1997;48: 1104-1106.
10. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-1072.
11. Adams D, Kuntzer T, Burger D, et al. Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol 1991;32:223-230.
12. Taylor BV, Gross L, Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996;47:951-955.
13. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994; 35:234-237.
14. Azulay JP, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994;44:429-432.
15. Van den Berg LH, Frannsen H, Wokke JHJ. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology 1995;45:987-988.
16. Van den Berg LH, Kerkhoff H, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995;59:248-252.
17. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237-242.
18. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997;63:765-769.
19. Azulay JP, Rihet P, Pouget J, et al. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 1997;62:391-394.
20. Jaspert A, Claus D, Grehl H, Neundörfer B. Multifocal motor neuropathy: clinical and electrophysiological findings. J Neurol 1996;243:684-692.
21. Léger JM, Ben Younes-Chennoufi A, Chassande B, et al. Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 1994;57S:46-49.
22. Bouche P, Moulonguet A, Ben Younes-Chennoufi A, et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995;59:38-44.
23. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544.
24. Van den Berg LH, Franssen H, Wokke JHJ. The long term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998;121:421-428.
25. Biessels GJ, Franssen H, van den Berg LH, et al. Multifocal motor neuropathy. J Neurol 1997;244:143-152.
26. Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology 1994;44:967-968.
27. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-783.
28. Van den Berg LH, Lokhorst H, Wokke JH. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997;48:1135.
29. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
30. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immuno-suppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397-401.
31. Pestronk A, Lopate G, Kornberg AJ, et al. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology 1994;44:2027-2031.